← Back
$BOLT All transactions

Bolt Biotherapeutics, Inc.

▲ BUY
4 / 10

Conviction

$ Value

$576

Shares

125

Price

$5

Filed

Feb 4

Why this score? (4/10)
  • Open market buy (+3)
  • Not a 10b5-1 plan (+1)

Insider

Name

Nemec Sarah

Title

Senior VP, Finance and PAO

CIK

0002023538

Roles

Officer

Transaction Details

Transaction Date

2025-12-05

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,415

Footnotes

These shares were acquired under the Issuer's Employee Stock Purchase Plan , in transactions that were exempt under Rule 16b-3(c). | For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2026.

Filing Info

Accession No.

0001193125-26-037690

Form Type

4

Issuer CIK

0001641281

Nemec Sarah's History

Date Ticker Type Value
2026-01-28 BOLT A $0
2025-12-12 BOLT A
2025-12-12 BOLT D
2025-12-12 BOLT A
2025-12-12 BOLT D
2025-12-12 BOLT A
2025-12-12 BOLT D
2025-12-12 BOLT A
2025-12-12 BOLT D
2025-12-12 BOLT A

Other Insiders at BOLT (90d)

Insider Bought Sold Last
Quinn William P.
President, CEO and CFO
$576 2026-01-28
Yonehiro Grant
Chief Operating Officer
2026-01-28
Nemec Sarah
Senior VP, Finance and PAO
2026-01-28